Dashboard
Manage Tickers

PRLDPrelude Therapeutics Inc

Nasdaq preludetx.com


$ 3.90 $ -0.34 (-8.35 %)    

Friday, 10-May-2024 12:13:32 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 3.73
$ 3.96
$ 0.00 x 0
$ 3.74 x 100
$ 3.90 - $ 3.99
$ 1.66 - $ 6.88
53,753
na
282.5M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-17-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-16-2021 12-31-2020 10-K
15 11-10-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

prelude-therapeutics-disclosed-laurent-chardonnet-will-no-longer-serve-as-cfo
Prelude Therapeutics Disclosed Laurent Cha...
04/10/2024 20:11:07

-SEC Filing

jmp-securities-initiates-coverage-on-prelude-therapeutics-with-market-outperform-rating-announces-price-target-of-7
JMP Securities Initiates Coverage On Prelu...
03/13/2024 09:20:21

JMP Securities analyst Reni Benjamin initiates coverage on Prelude Therapeutics (NASDAQ:PRLD) with a Market Outperform ratin...

hc-wainwright--co-downgrades-prelude-therapeutics-to-neutral-announces-5-price-target
HC Wainwright & Co. Downgrades Prelude The...
02/20/2024 14:03:38

HC Wainwright & Co. analyst Robert Burns downgrades Prelude Therapeutics (NASDAQ:PRLD) from Buy to Neutral and announces...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
02/16/2024 17:31:13

prelude-therapeutics-reports-fy23-financial-results-and-outlines-key-objectives-for-2024-fy23-eps-202-vs-244-yoy-current-cash-runway-into-2026-with-2329m-in-cash-cash-equivalents-and-marketable-securities-as-of-december-31-2023
Prelude Therapeutics Reports FY23 Financia...
02/15/2024 21:40:04

First-in-class IV SMARCA2 degrader and potentially best-in-class CDK9 inhibitor on track to generate potential proof-of-concept...

morgan-stanley-downgrades-prelude-therapeutics-heres-what-you-need-to-know
Morgan Stanley Downgrades Prelude Therapeu...
12/19/2023 17:00:25

morgan-stanley-downgrades-prelude-therapeutics-to-underweight-lowers-price-target-to-4
Morgan Stanley Downgrades Prelude Therapeu...
12/19/2023 14:33:08

Morgan Stanley analyst Jeffrey Hung downgrades Prelude Therapeutics (NASDAQ:PRLD) from Equal-Weight to Underweight and lower...

prelude-therapeutics-entered-into-a-securities-purchase-agreement-with-institutional-investors-to-which-the-company-agreed-to-issue-and-sell-pre-funded-warrants-to-purchase-up-to-7936759-shares-of-voting-common-stock-at-a-price-of-31499-per-warrant
Prelude Therapeutics Entered Into A Securi...
12/11/2023 14:24:19

On December 11, 2023, Prelude Therapeutics Incorporated, a Delaware corporation (the "Company"), entered into a securit...

hc-wainwright--co-maintains-buy-on-prelude-therapeutics-lowers-price-target-to-5
HC Wainwright & Co. Maintains Buy on Prelu...
11/07/2023 18:20:28

HC Wainwright & Co. analyst Robert Burns maintains Prelude Therapeutics (NASDAQ:PRLD) with a Buy and lowers the price ta...

prelude-therapeutics-q3-eps-045-beats-058-estimate
Prelude Therapeutics Q3 EPS $(0.45) Beats ...
11/01/2023 21:50:54

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of ...

Core News & Articles
Prelude Therapeutics And AbCellera Enter P...
11/01/2023 21:18:40

Prelude Therapeutics Incorporated ("Prelude") (NASDAQ:PRLD) and AbCellera (NASDAQ:ABCL) today announced a multi-year, m...

best-buy-to-rally-more-than-21-here-are-10-top-analyst-forecasts-for-thursday
Best Buy To Rally More Than 21%? Here Are ...
10/19/2023 12:03:18

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

the-latest-analyst-ratings-for-prelude-therapeutics
The Latest Analyst Ratings for Prelude The...
10/19/2023 12:00:42

hc-wainwright--co-maintains-buy-on-prelude-therapeutics-lowers-price-target-to-6
HC Wainwright & Co. Maintains Buy on Prelu...
10/19/2023 11:06:24

HC Wainwright & Co. analyst Robert Burns maintains Prelude Therapeutics (NASDAQ:PRLD) with a Buy and lowers the price ta...

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
10/10/2023 17:09:29

  Tuesday saw 132 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-friday
Stocks That Hit 52-Week Lows On Friday
09/15/2023 15:52:24

  Friday's session saw 169 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-wednesday
Stocks That Hit 52-Week Lows On Wednesday
08/23/2023 17:16:36

  Wednesday's session saw 150 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
08/22/2023 17:51:20

  On Tuesday, 210 companies reached new 52-week lows.

hc-wainwright--co-reiterates-buy-on-prelude-therapeutics-maintains-17-price-target
HC Wainwright & Co. Reiterates Buy on Prel...
08/17/2023 10:32:07

HC Wainwright & Co. analyst Robert Burns reiterates Prelude Therapeutics (NASDAQ:PRLD) with a Buy and maintains $17 pric...

morgan-stanley-reiterates-equal-weight-on-prelude-therapeutics-maintains-10-price-target
Morgan Stanley Reiterates Equal-Weight on ...
08/04/2023 18:46:21

Morgan Stanley analyst Jeffrey Hung reiterates Prelude Therapeutics (NASDAQ:PRLD) with a Equal-Weight and maintains $10 pric...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION